Bespoke library docking for 5-HT<sub>2A</sub> receptor agonists with antidepressant activity.
Abstract
There is considerable interest in screening ultralarge chemical libraries for ligand discovery, both empirically and computationally<sup>1-4</sup>. Efforts have focused on readily synthesizable molecules, inevitably leaving many chemotypes unexplored. Here we investigate structure-based docking of a bespoke virtual library of tetrahydropyridines-a scaffold that is poorly sampled by a general billion-molecule virtual library but is well suited to many aminergic G-protein-coupled receptors. Using three inputs, each with diverse available derivatives, a one pot C-H alkenylation, electrocyclization and reduction provides the tetrahydropyridine core with up to six sites of derivatization<sup>5-7</sup>. Docking a virtual library of 75 million tetrahydropyridines against a model of the serotonin 5-HT<sub>2A</sub> receptor (5-HT<sub>2A</sub>R) led to the synthesis and testing of 17 initial molecules. Four of these molecules had low-micromolar activities against either the 5-HT<sub>2A</sub> or the 5-HT<sub>2B</sub> receptors. Structure-based optimization led to the 5-HT<sub>2A</sub>R agonists (R)-69 and (R)-70, with half-maximal effective concentration values of 41 nM and 110 nM, respectively, and unusual signalling kinetics that differ from psychedelic 5-HT<sub>2A</sub>R agonists. Cryo-electron microscopy structural analysis confirmed the predicted binding mode to 5-HT<sub>2A</sub>R. The favourable physical properties of these new agonists conferred high brain permeability, enabling mouse behavioural assays. Notably, neither had psychedelic activity, in contrast to classic 5-HT<sub>2A</sub>R agonists, whereas both had potent antidepressant activity in mouse models and had the same efficacy as antidepressants such as fluoxetine at as low as 1/40th of the dose. Prospects for using bespoke virtual libraries to sample pharmacologically relevant chemical space will be considered.
Topics & conditions
Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.
Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.